Effective blood concentration of micafungin for pulmonary aspergillosis

Biological and Pharmaceutical Bulletin

Volumn 29, Issue 9, 2006, Pages 1886-1891

  Shimoeda, Sadahiko ^a   Ohta, Shin ^a   Kobayashi, Hikaru ^a   Yamato, Susumu ^b   Sasaki, Mutsuko ^b   Kawano, Kenji ^b  

^a NAGANO RED CROSS HOSPITAL   (Japan)

^b NIIGATA UNIVERSITY OF PHARMACY AND APPLIED LIFE SCIENCES   (Japan)

Author keywords

Aspergillus; Blood level; Hematological disease; Micafungin

Indexed keywords

MICAFUNGIN;

ADULT; ARTICLE; CLINICAL ARTICLE; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG HALF LIFE; FEMALE; HUMAN; LIVER DYSFUNCTION; LUNG ASPERGILLOSIS; MALE;

ADULT; AGED; ANTIFUNGAL AGENTS; ASPERGILLOSIS; FEMALE; HUMANS; LIPOPROTEINS; LUNG DISEASES, FUNGAL; MALE; MIDDLE AGED; PEPTIDES, CYCLIC;

EID: 33748349686     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.29.1886     Document Type: Article

References (18)

1. Kohno S., Yamaguchi H., Jpn. J. Chemother., 50(Suppl. 1), 1-7 (2002).
2. Ikeda F., Otomo K., Nakai T., Morishita Y., Maki K., Tawara S., Mutoh S., Matsumoto F., Kuwahara S., Jpn. J. Chemother., 50(Suppl. 1), 8-19 (2002).
3. Yamato Y., Kaneko H.,Yamasaki S., Fujiwara T., Katashima M., Kawamura A., Terakawa M., Kagayama A., Jpn. J. Chemother., 50(Suppl. 1), 80-87 (2002).
4. Shimoeda S., Ohta S., Kobayashi H., Saitou H., Satou C., Ebara K., Yamato S., Shimada K., Tanaka M., Kawano K., Jpn. J. Pham. Health Care Sci., 30, 203-210 (2004).
5. Shimoeda S., Ohta S., Kobayashi H., Saitou H., Kubota A., Yamato S., Shimada K., Sasaki M., Kawano K., Biol. Pharm. Bull., 28, 477-480 (2005).
6. Azuma J., Nakahara K., Kagayama A., Fujiwara S., Kawamura K., Mukai T., Jpn. J. Chemother., 50(Suppl. 1), 148-154 (2002).
7. Michael E. W., Mary A. K., Lloyd Y. Y., "Basic Clinical Pharmacokinetics," 3rd ed., Part 1, Applied Therapeutics, Washington, 1994, pp. 37-52.
8. Ascioglu S., Rex J. H., de Pauw B., Bennett J. E., Bille J., Crokaert F., Denning D. W., Donnelly J. P., Edwards J. E., Erjavec Z., Fiere D., Lortholary O., Maertens J., Meis J. F., Patterson T. F., Ritter J., Selleslag D., Shah P. M., Stevens D. A., Walsh T. J., Clin. Infect. Dis., 34, 7-14 (2002).
9. van Burik J. A., Ratanatharathorn V., Stepan D. E., Miller C. B., Lipton J. H., Vesole D. H., Bunin N., Wall D. A., Hiemenz J. W., Satoi Y., Lee J. M., Walsh T. J., Clin. Infect. Dis., 39, 1407-1416 (2004).
10. Hebert M. F., Smith H. E., Marbury T. C., Swan S. K., Smith W. B., Townsend R. W., Buell D., Keirns J., Bekersky I., J. Clin. Pharmacol., 45, 1145-1152 ( 2005).
11. Denning D. W., Lancet, 362, 1142-1151 (2003).
12. Mori T., Matsumura M., Nippon Ishinkin Gakkai Zasshi, 40, 223-230 (1999).
13. Kami M., Tanaka Y., Kanda Y., Ogawa S., Masumoto T., Ohtomo K., Matsumura T., Saito T., Machida U., Kashima T., Hirai H., Haematologica, 85, 745-752 (2000).
14. Andes D., Antimicrob. Agents Chemother., 47, 1179-1186 (2003).
15. Ernst E. J., Roling E. E., Petzold C. R., Keele D. J., Klepser M. E., Antimicrob. Agents Chemother., 46, 3846-3853 (2002).
16. Groll A. H., Mickiene D., Petraitis V., Petraitiene R., Ibrahim K. H., Piscitelli S. C., Bekersky I., Walsh T. J., Antimicrob. Agents Chemother., 45, 3322-3327 (2001).
17. Lewis R. E., Kontoyiannis D. P., J. Antimicrob. Chemother., 56, 887-892 (2005).
18. Heyn K., Tredup A., Salvenmoser S., Muller F. M., Antimicrob. Agents Chemother., 49, 5157-5159 (2005).